Skip to Main Content
Creatv Bio
  • Home
  • About
    • Company
    • Management Team
    • News
  • Assay
  • BioPharma Services
  • Publications
    • All Publications
    • Journals
    • Presentations
  • Training Videos
  • Contact
Journals & Presentations

Publications

Showcasing Creatv Bio’s contributions to cancer diagnostics and circulating tumor cell research.

  • All Topics
  • Blood-based Tumor Markers 8
  • Cancer Associated Macrophage-like Cells (CAMLs) 1
  • Cancer Screening 10
  • Clinical Trials and Biopharma Services 12
  • Companion/Complementary Diagnostics 3
  • Companion Diagnostics for PD-L1 18
  • Detection of Recurrence 1
  • Determination of Cancer Aggressiveness 26
  • Determination of Response to Therapy 13
  • Microfilters 3
  • Monitoring Change of PD-L1 Expression 18
  • Residual Disease 1
  • Sequential Monitoring of Tumor Marker Status During Therapy 5
  • Treatment Modalities 12
  • Tumor Macrophage Hybrid Cells (TMHCs) 1
  • Tumor Types We Have Tested 1
AACR 2022 Poster Presentation

Changes in Circulating Tumor Associated Cells Predicts Progression Free and Overall Survival in Metastatic TNBC Patients after Induction with the Anti-CCR5 Drug Leronlimab

AACR 2021 Poster Presentation

CCR5 upregulation in two subtypes of tumor associated circulating cells predict worse prognosis in metastatic breast cancer

EDRN 2021 Poster Presentation

Combining Automated Image Measurements, Blood Biomarkers, and Clinical Data for Improved Decisions in Diagnostic Mammography

© 2026 Creatv Bio, a Division of Creatv MicroTech, Inc.
Creatv Bio on LinkedIn Creatv Bio on Facebook
Privacy Policy Terms of Use Login

Research Use Only (RUO) Disclaimer

The Creatv Bio website and the information provided through this website, including text, outcomes, charts and graphics, are intended solely for Research Use Only (RUO) and are intended for qualified research, pharmaceutical, biotechnology, and academic research organizations. They should not be considered medical advice and are not intended for clinical diagnostic use, patient testing, patient management, or use by patients or healthcare professionals for making medical decisions.

The products, services, and information described on this website have not been, evaluated, cleared, approved, or authorized by the U.S. Food and Drug Administration (FDA) for clinical diagnostic use and are not intended to be used for diagnosis, treatment, prevention, or monitoring of disease. Reliance on any data or information provided on this website is strictly at your own risk.

Creatv Bio’s RUO activities are separate from clinical laboratory testing performed under CLIA. Nothing on this website should be interpreted as representing that the RUO products or services constitute CLIA-certified patient testing.

If you are a patient or healthcare professional seeking clinical laboratory testing, please visit the LifeTracDx website.